Sexual Dimorphism, the Aging Kidney, and Involvement of Nitric Oxide Deficiency

Seminars in Nephrology

Volumn 29, Issue 6, 2009, Pages 569-578

  Baylis, Chris ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

androgen; asymmetric dimethylarginine; cardiovascular events; dimethylarginine dimethylaminohydrolase; Estrogen

Indexed keywords

ANDROGEN RECEPTOR; ARGININE; CONJUGATED ESTROGEN; DIMETHYLARGININASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; N(G),N(G) DIMETHYLARGININE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; SUPEROXIDE; TESTOSTERONE;

AGING; ALBUMINURIA; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; ENDOTHELIAL DYSFUNCTION; ESTROGEN THERAPY; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY DISEASE; KIDNEY HYPERTROPHY; KIDNEY PLASMA FLOW; NONHUMAN; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; RENOVASCULAR HYPERTENSION; SEX DIFFERENCE;

AGING; ANDROGENS; ANIMALS; ESTROGENS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; SEX CHARACTERISTICS; SEX FACTORS;

EID: 71549120119     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2009.07.003     Document Type: Article

References (86)

1. Levi M., and Rowe J.W. Renal function and dysfunction in aging. In: Seldin D.W., and Giebisch G. (Eds). The kidney: physiology and pathophysiology (1992), Raven Press, New York 3433-3456
2. Baylis C., and Corman B. The aging kidney: insights from experimental studies. [editorial]. J Am Soc Nephrol 9 (1998) 699-709
3. Bleyer A.J., Shemanski L.R., Burke G.L., Hansen K.J., and Appel R.G. Tobacco, hypertension and vascular disease: risk factors for renal functional decline in an older population. Kidney Int 57 (2000) 2072-2079
4. Hemmelgarn B.R., Zhang J., Manns B.J., Tonelli M., Larsen E., Ghali W.A., et al. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int 69 (2006) 2155-2161
5. Kasiske B.L. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int 31 (1987) 1153-1159
6. Yamagata K., Ishida K., Sairenchi T., Takahashi H., Ohba S., Shiigai T., et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int 71 (2007) 159-166
7. Xue J.L., Eggers P.W., Agodoa L.Y., Foley R.N., and Collins A.J. Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged Medicare beneficiaries. J Am Soc Nephrol 18 (2007) 1299-1306
8. Luyckx V.A., and Brenner B.M. Low birth weight, nephron number, and kidney disease. Kidney Int Suppl 97 (2005) S68-S77
9. Lindeman R.D., Tobin J., and Shock N.W. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33 (1985) 278-285
10. Berg U.B. Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors. Nephrol Dial Transplant 21 (2006) 2577-2582
11. Wesson Jr. L.G. Renal hemodynamics in physiological states. Physiology of the human kidney (1969), Grune and Stratton, New York 96-108
12. McLachlan M.S., Guthrie J.C., Anderson C.K., and Fulker M.J. Vascular and glomerular changes in the ageing kidney. J Pathol 121 (1977) 65-78
13. Neugarten J., Gallo G., Silbiger S., and Kasiske B. Glomerulosclerosis in aging humans is not influenced by gender. Am J Kidney Dis 34 (1999) 884-888
14. Baylis C. Age-dependent glomerular damage in the rat: dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor. J Clin Invest 94 (1994) 1823-1829
15. Anderson S., Rennke H.G., and Zatz R. Glomerular adaptations with normal aging and with long-term converting enzyme inhibition in rats. Am J Physiol 267 (1994) F35-F43
16. Remuzzi A., Puntorieri S., Mazzoleni A., and Remuzzi G. Sex related differences in glomerular ultrafiltration and proteinuria in Munich Wistar rats. Kidney Int 34 (1988) 481-486
17. Fliser D., Franek E., Joest M., Block S., Mutschler E., and Ritz E. Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int 51 (1997) 1196-1204
18. Schmieder R.E., Schachinger H., and Messerli F.H. Accelerated decline in renal perfusion with aging in essential hypertension. Hypertension 23 (1994) 351-357
19. Fujihara C.K., Limongi D.M.Z.P., DeOliveira H.C.F., and Zatz R. Absence of focal glomerulosclerosis in aging analbuminemic rats. Am J Physiol 262 (1992) R947-R954
20. Kielstein J.T., Bode-Boger S.M., Frolich J.C., Ritz E., Haller H., and Fliser D. Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation 107 (2003) 1891-1895
21. Neugarten J., Acharya A., and Silbiger S.R. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 11 (2000) 319-329
22. Zheng F., Plati A.R., Potier M., Schulman Y., Berho M., Banerjee A., et al. Resistance to glomerulosclerosis in B6 mice disappears after menopause. Am J Pathol 162 (2003) 1339-1348
23. Elliot S.J., Karl M., Berho M., Potier M., Zheng F., Leclercq B., et al. Estrogen deficiency accelerates progression of glomerulosclerosis in susceptible mice. Am J Pathol 162 (2003) 1441-1448
24. Dubey R.K., Gillespie D.G., Keller P.J., Imthurn B., Zacharia L.C., and Jackson E.K. Role of methoxyestradiols in the growth inhibitory effects of estradiol on human glomerular mesangial cells. Hypertension 39 (2002) 418-424
25. Dubey R.K., and Jackson E.K. Estrogen-induced cardiorenal protection: potential cellular, biochemical and molecular mechanisms. Am J Physiol Renal Physiol 280 (2001) F365-F388
26. Guccione M., Silbiger S., Lei J., and Neugarten J. Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2. Am J Physiol Renal Physiol 282 (2002) F164-F169
27. Kwan G., Neugarten J., Sherman M., Ding Q., Fotadar U., Lei J., et al. Effects of sex hormones on mesangial cell proliferation and collagen synthesis. Kidney Int 50 (1996) 1173-1179
28. Neugarten J., Medve I., Lei J., and Silbiger S.R. Estradiol suppresses mesangial cell type I collagen synthesis via activation of the MAP kinase cascade. Am J Physiol 77 (1999) F875-F881
29. Xiao S., Gillespie D.G., Baylis C., Jackson E.K., and Dubey R.K. Effects of estradiol and its metabolites on glomerular endothelial no synthesis and mesangial cell growth. Hypertension 37 (2001) 645-650
30. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280 (1998) 605-613
31. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al., Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
32. Dubey R.K., Imthurn B., Barton M., and Jackson E.K. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc Res 66 (2005) 295-306
33. Meyer M.R., Haas E., and Barton M. Gender differences of cardiovascular disease new perspectives for estrogen receptor signaling. Hypertension 47 (2006) 1019-1026
34. Jelinsky S.A., Harris H.A., Brown E.L., Flanagan K., Zhang X., Tunkey C., et al. Global transcription profiling of estrogen activity: estrogen receptor regulates gene expression in the kidney. Endocrinology 144 (2003) 701-710
35. Sun J., Langer W.J., Devish K., and Lane P.H. Compensatory kidney growth in estrogen receptor-alpha null mice. Am J Physiol Renal Physiol 290 (2006) F319-F323
36. Lovegrove A.S., Sun J., Gould K.A., Lubahn D.B., Korach K.S., and Lane P.H. Estrogen receptor-mediated events promote sex-specific diabetic glomerular hypertrophy. Am J Physiol Renal Physiol 287 (2004) F586-F591
37. Wells C.C., Riazi S., Mankhey R.W., Bhatti F., Ecelbarger C., and Maric C. Diabetic nephropathy is associated with decreased circulating estradiol levels and imbalance in the expression of renal estrogen receptors. Gend Med 2 (2005) 227-237
38. Sharma P.K., and Thakur M.K. Estrogen receptor a expression in mice kidney shows sex differences during aging. Biogerontology 5 (2004) 375-381
39. Potier M., Karl M., Zheng F., Elliot S.J., Striker G.E., and Striker L.J. Estrogen-related abnormalities in glomerulosclerosis-prone mice reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens. Am J Pathol 160 (2002) 1877-1885
40. Esqueda D., Craig T., and Hinojosa-Laborde C. Effect of ovariectomy on renal estrogen receptor-alpha and renal estrogen receptor-beta in young salt-sensitive and resistant rats. Hypertension 50 (2007) 768-772
41. Elliot S.J., Berho M., Korach K., Doublier S., Lupia E., Striker G.E., et al. Gender-specific effects of endogenous testosterone: female alpha-estrogen receptor-deficient C57Bl/6J mice develop glomerulosclerosis. Kidney Int 72 (2007) 464-472
42. Zhu Y., Bian Z., Lu P., Karas R.H., Bao L., Cox D., et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 295 (2002) 505-508
43. Gabel S.A., Walker V.R., London R.E., Steenbergen C., Korach K.S., and Murphy E. Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury. J Mol Cell Cardiol 38 (2005) 289-297
44. Potier K.M.M., Schulman I.H., Rivera A., Werner H., Fornoni A., and Elliot S.J. Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cells. Endocrinology 146 (2005) 889-900
45. Stier Jr. C.T., Chander P.N., Rosenfeld L., and Powers C.A. Estrogen promotes microvascular pathology in female stroke-prone spontaneously hypertensive rats. Am J Physiol Endocrinol Metab 285 (2003) E232-E239
46. Oestreicher E.M., Guo C., Seely E.W., Kikuchi T., Martinez-Vasquez D., Jonasson L., et al. Estradiol increases proteinuria and angiotensin II type 1 receptor in kidneys of rats receiving L-NAME and angiotensin II. Kidney Int 70 (2006) 1759-1768
47. Joles J.A., van Goor H., and Koomans H.A. Estrogen induces glomerulosclerosis in analbuminemic rats. Kidney Int 53 (1998) 862-868
48. Gades M.D., Stern J.S., van Goor H., Nguyen D., Johnson P.R., and Kaysen G.A. Estrogen accelerates the development of renal disease in female obese Zucker rats. Kidney Int 53 (1998) 130-135
49. Lombet J.R., Adler S.G., Anderson P.S., Nast C.C., Olsen D.R., and Glassock R.J. Sex vulnerability in the subtotal nephrectomy model of glomerulosclerosis in the rat. J Lab Clin Med 114 (1989) 66-74
50. Reckelhoff J.F., and Baylis C. Glomerular metalloprotease activity is suppressed by androgens in the ageing kidney. J Am Soc Nephrol 3 (1993) 1835-1838
51. Reckelhoff J.F., Yanes L.L., Iliescu R., Fortepiani L.A., and Granger J.P. Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease. Am J Physiol Renal Physiol 289 (2005) F941-F948
52. Littleton-Kearney M., and Hurn P.D. Testosterone as a modulator of vascular behavior. Biol Res Nurs 5 (2004) 276-285
53. Rahman F., and Christian H.C. Non-classical actions of testosterone: an update. Trends Endocrinol Metab 18 (2007) 371-378
54. Brinkworth G.D., Noakes M., Moran L.J., Norman R., and Clifton P.M. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome. BJOG 113 (2006) 1308-1314
55. Laughlin G.A., Barrett-Connor E., and May S. Sex-specific association of the androgen to oestrogen ratio with adipocytokine levels in older adults: the Rancho Bernardo Study. Clin Endocrinol 65 (2006) 506-513
56. Rizzo M., Rini G.B., and Carmina E. Androgen excess and cardiovascular risk. Minerva Endocrinol 32 (2007) 67-71
57. Liu P.Y., Death A.K., and Handelsman D.J. Androgens and cardiovascular disease. Endocr Rev 24 (2003) 313-340
58. Baltatu O., Cayla C., Iliescu R., Andreev D., Jordan C., and Bader M. Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene. J Am Soc Nephrol 13 (2002) 2681-2687
59. Nathan L., Shi W., Dinh H., Mukherjee T.K., Wang X., Lusis A.J., et al. Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci U S A 98 (2001) 3589-3593
60. Mukherjee T.K., Dinh H., Chaudhuri G., and Nathan L. Testosterone attenuates expression of vascular cell adhesion molecule 1 by conversion to estradiol in endothelial cells: implications in atherosclerosis. Proc Natl Acad Sci U S A 99 (2002) 4055-4060
61. Monster T.B., Janssen W.M., de Jong P.E., de Jong-van den Berg L.T., and Prevention of RenalVascular End Stage Disease Study Group. Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria. Arch Intern Med 161 (2001) 2000-2005
62. Ahmed S.B., Culleton B.F., Tonelli M., Klarenbach S.W., Macrae J.M., Zhang J., et al., Alberta Kidney Disease Network. Oral estrogen therapy in postmenopausal women is associated with loss of kidney function. Kidney Int 74 (2008) 370-376
63. Agarwal M., Selvan V., Freedman B.I., Liu Y., and Wagenknecht L.E. The relationship between albuminuria and hormone therapy in postmenopausal women. Am J Kidney Dis 45 (2005) 1019-1025
64. Silbiger S. The effects of hormone replacement therapy on renal function. Nat Clin Pract Nephrol 5 (2009) 6-7
65. Baylis C. Nitric oxide deficiency in chronic kidney disease. Gottschalk Lecture 2007. Am J Physiol Renal Physiol 294 (2008) F1-F9
66. Baylis C. Mini-review: changes in renal hemodynamics and structure in the aging kidney; sexual dimorphism and the nitric oxide system. Exp Gerontol 40 (2005) 271-278
67. Erdely A., Greenfeld Z., Wagner L., and Baylis C. Sexual dimorphism in the aging kidney; inverse relationship between injury and nitric oxide system. Kidney Int 63 (2003) 1021-1026
68. Hill C., Lateef A.M., Engels K., Samsell L., and Baylis C. Basal and stimulated nitric oxide in control of kidney function in the aging rat. Am J Physiol 272 (1997) R1747-R1753
69. Sonaka I., Futami Y., and Maki T. L-arginine-nitric oxide pathway and chronic nephropathy in aged rats. J Gerontol Biol Sci 49 (1990) B157-B161
70. Schmidt R.J., Beierwaltes W.H., and Baylis C. Aging and alterations in dietary sodium intake on total nitric oxide production in normal man. Am J Kidney Dis 37 (2001) 900-908
71. Lyons D., Roy S., Patel M., Benjamin N., and Swift C.G. Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age. Clin Sci 93 (1997) 519-525
72. Celermajer D.S., Sorensen K.E., Spiegelhalter D.J., Georgakopoulos D., Robinson J., and Deanfield J.E. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 24 (1994) 471-476
73. Forte P., Kneale B.J., Milne E., Chowienczyk P.J., Johnston A., Benjamin N., et al. Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension 32 (1998) 730-734
74. Neugarten J., Ding Q., Friedman A., Le J., and Silbiger S. Sex hormones and renal nitric oxide synthases. J Am Soc Nephrol 8 (1997) 1240-1246
75. Holden D.P., Cartwright J.E., Nussey S.S., and Whitley G.S. Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine. Circulation 108 (2003) 1575-1580
76. Orshal J.M., and Khalil R.A. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 286 (2004) R233-R249
77. Verhagen A.M., Attia D.M., Koomans H.A., and Joles J.A. Male gender increases sensitivity to proteinuria induced by mild NOS inhibition in rats: role of sex hormones. Am J Physiol Renal Physiol 279 (2000) F664-F670
78. Vasudevan H., Nagareddy P.R., and McNeill J.H. Gonadectomy prevents endothelial dysfunction in fructose-fed male rats, a factor contributing to the development of hypertension. Am J Physiol Heart Circ Physiol 291 (2006) H3058-H3064
79. Attia D.M., Goldschmeding R., Attia M.A., Boer P., Koomans H.A., and Joles J.A. Male gender increases sensitivity to renal injury in response to cholesterol loading. Am J Physiol Renal Physiol 284 (2003) F718-F726
80. Reckelhoff J.F., Kellum J.A., Blanchard E.J., Bacon E.E., Wesley E.J., and Kruckeberger W.C. Changes in nitric oxide precursor, L-arginine and metabolites, nitrate and nitrite, with aging. Life Sci 55 (1994) 1895-1902
81. Schulze F., Maas R., Freese R., Schwedhelm E., Silberhorn E., and Böger R.H. Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects. Eur J Clin Invest 35 (2005) 622-626
82. Bode-Boger S.M., Muke J., Surdacki A., Brabant G., Boger R.H., and Frolich J.C. Oral L-arginine improves endothelial function in healthy individuals older than 70 years. Vasc Med 8 (2003) 77-81
83. Verhoeven M.O., Hemelaar M., Teerlink T., Kenemans P., and van der Mooren M.J. Effects of intranasal versus oral hormone therapy on asymmetric dimethylarginine in healthy postmenopausal women: a randomized study. Atherosclerosis 195 (2007) 181-188
84. Moens A.L., and Kass D.A. Tetrahydrobiopterin and cardiovascular disease. Arterioscler Thromb Vasc Biol 26 (2006) 2439-2444
85. Druhan L.J., Forbes S.P., Pope A.J., Chen C.A., Zweier J.L., and Cardounel A.J. Regulation of eNOS-derived superoxide by endogenous methylarginines. Biochemistry 47 (2008) 7256-7263
86. Vlassara H., and Palace M.R. Glycoxidation: the menace of diabetes and aging. Mt Sinai J Med 70 (2003) 232-241